GW Pharma wins historic FDA nod for cannabis-based drug by Eric Sagonowsky Monday, June 25, 2018 The FDA just approved Epidiolex, the cannabis-based drug that GW Pharma has been toiling over for years, to treat two rare and serious forms of epilepsy.
